Skip to main content

Table 5 Postoperative Outcomes

From: Right ventricular failure following left ventricular assist device implantation is associated with a preoperative pro-inflammatory response

 

WBC < 10.5 K/μL (n = 362)

WBC > 10.5 K/μL (n = 127)

P Value

Total ICU LOS (mean days)

10.95 + 17.22

15.73 + 34.92

0.046

Total LOS (mean days)

26.06 + 20.15

30.86 + 35.58

0.064

Total Days Readmit (mean days)

38.14 + 54.11

31.94 + 45.47

0.248

Device Infection

95 (26.2%)

26 (20.5%)

0.195

Device Exchange Infection

21 (5.8%)

7 (5.5%)

0.904

Late AV Intervention

5 (1.4%)

1 (0.8%)

0.601

Stroke

94 (26.0%)

32 (25.2%)

0.864

Hemolysis

87 (24.0%)

28 (22.0%)

0.650

Postop Dialysis/CVVH

12 (3.3%)

11 (8.7%)

0.014

Postop Perm Dialysis

6 (1.7%)

3 (2.4%)

0.611

LVAD Death

107 (29.6%)

41 (32.3%)

0.565

Transplant

132 (36.5%)

42 (33.1%)

0.492

Operative Mortality

16 (4.4%)

8 (6.3%)

0.399

RV Failure

21 (5.8%)

17 (13.4%)

0.006

RVAD

16 (4.4%)

14 (11.0%)

0.008

Duration of RVAD (median)

17.0 (IQR = 18.0)

20.50 (IQR = 74.0)

0.452

Nitric Oxide Use

356 (98.3%)

125 (98.4%)

0.950

Nitric Duration (median days)

2.0 (IQR = 2.0)

2.0 (IQR = 2.0)

0.514

  1. Hospital stay times are expressed as mean + standard deviation. Duration of RVAD and nitric oxide use is expressed as median with interquartile range